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ORIGINAL RESEARCH REPORT
The CS Sulfation Motifs 4C3, 7D4, 3B3[-]; and Perlecan
Identify Stem Cell Populations and Their Niches, Activated
Progenitor Cells and Transitional Areas of Tissue
Development in the Fetal Human Elbow
Anthony J. Hayes,1 Clare E. Hughes,2 Susan M. Smith,3 Bruce Caterson,2
Christopher B. Little,3,4 and James Melrose3–5
We compared the immunohistochemical distribution of (1) the novel chondroitin sulfate (CS) sulfation motifs
7D4, 4C3, and 3B3[-], (2) native heparan sulfate (HS) and D-HS ‘‘stubs’’ generated by heparitinase III
digestion and (3) the HS-proteoglycan (PG), perlecan, in the fetal human elbow joint. Putative stem cell
populations associated with hair bulbs, humeral perichondrium, humeral and ulnar rudiment stromal/perivas-
cular tissues expressed the CS motifs 4C3, 7D4, and 3B3[-] along with perlecan in close association but not
colocalized. Chondrocytes in the presumptive articular cartilage of the fetal elbow expressed the 4C3 and 7D4
CS sulfation motifs consistent with earlier studies on the expression of these motifs in knee cartilage following
joint cavitation. This study also indicated that hair bulbs, skin, perichondrium, and rudiment stroma were all
perlecan-rich progenitor cell niches that contributed to the organization and development of the human fetal
elbow joint and associated connective tissues. One of the difficulties in determining the precise role of stem
cells in tissue development and repair processes is their short engraftment period and the lack of specific
markers, which differentiate the activated stem cell lineages from the resident cells. The CS sulfation motifs
7D4, 4C3, and 3B3[-] decorate cell surface PGs on activated stem/progenitor cells and thus can be used to
identify these cells in transitional areas of tissue development and in repair tissues and may be applicable to
determining a more precise mode of action of stem cells in these processes. Isolation of perlecan from 12 to 14
week gestational age fetal knee rudiments demonstrated that perlecan in these fetal tissues was a HS-CS hybrid
PG further supporting roles for CS in tissue development.
Introduction
The capacity of mesenchymal stem cells (MSCs) forself-renewal and directed differentiation and their ability
to modulate the local microenvironment through their anti-
inflammatory and immunosuppressive properties [1–3]
makes them attractive candidates for a range of cell-based
therapies and considerable interest has centered around their
use in regenerative medicine. MSCs are known to home to
sites of injury where paracrine effector molecules and subtle
extracellular matrix (ECM) feedback cues are believed to
direct cell lineage development [1,4]. Demonstration of the
engraftment of MSCs to defect sites can be difficult to
demonstrate due to a lack of reliable specific MSC markers,
yet beneficial therapeutic effects are still demonstrable for a
period of weeks after administration of the MSCs, thus the
precise mode of action of the MSCs in tissue repair processes
remains elusive [1,4].
The aim of this study was therefore to determine whether
the novel chondroitin sulfate (CS) sulfation motifs identified
by monoclonal antibodies (mAbs) 4C3, 7D4, and 3B3[-]
could be used to identify activated stem cell lineages involved
in tissue development. The fetal human elbow was selected as
a target tissue of interest since these are of a convenient size
and contain a diverse number of known or putative stem cell
niches in the developing articular cartilage, perichondrium,
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and perivascular/stromal tissues associated with the rudiment
skin and hair follicle development. Earlier studies have
demonstrated that the CS sulfation motifs 7D4 and 4C3
decorate cell associated proteoglycans (PGs), which serve to
immobilize growth factors/morphogens actively involved in
tissue development [5].
The unique distributions of these CS sulfation motifs with
discrete populations of surface zone progenitor cells in knee
articular cartilage [6–9] and in tissue niches associated with
histogenesis and tissue differentiation [10–12] indicate that
they identify an early stage of stem/progenitor cell differ-
entiation. Previous studies indicate that these 4C3, 7D4, and
3B3[-] positive progenitor cell populations played roles in
hematopoiesis, skin morphogenesis, chondrogenesis, and
intervertebral disc (IVD) development [6–9,11,12]. The
findings of this study indicate that these CS sulfation motifs
also have important roles to play in the development of
the human fetal elbow joint and its associated connective
tissues.
The relevance of CS to the proposed study is also now
apparent from a number of recent studies that have established
roles for CS in the control of MSC proliferation and differen-
tiation [13]. CS has an indispensable role to play in the devel-
opment of MSC pluripotency [13] and oversulfated CS can
induce osteogenic differentiation of humanMSCs independant
of bone morphogenetic protein (BMP)-2 and transforming
growth factor-b1 (TGF-b1) [14]. CS can also modulate the
adhesiveness of MSCs in the niche environment to ECM
components such as E-cadherin and also alter integrin- de-
pendent cell-matrix attachments influencing the development
of activated MSC/progenitor cell lineages [15–19].
The elbow joint is a complex hinge joint consisting of (1)
humero-radial, (2) humero-ulnar, and (3) radio-ulnar joints
[20]. Numerous ligaments, tendons and muscles, and a sy-
novial joint capsule surround the elbow joint. The articu-
lating surfaces of the elbow joint are located between the
trochlea of the humerus and ulna and between the humeral
capitulum and head of the radius [20]. Ulnar and radial
FIG. 1. Composite picture of two
12-week-old and one 14-year-old
human fetal elbow joints. Toluidine
blue-stained rudiments (a, g). Higher
power view of the boxed area in (a)
depicting perlecan immunolocaliza-
tion (b). Macroscopic immuno-
localization of perlecan in a second
12-week-old elbow joint rudiment
(c). The boxed areas (d, e) in seg-
ment (c) are also presented sepa-
rately at higher magnification in (d)
and (e). Putative stem cell niches
bordered by perlecan in the peri-
chondrium (b) and in the surface
regions of the developing articular
cartilage (d, e) and the cartilage
rudiment are labeled. Immuno-
localization of perlecan (f) and
toluidine blue-stained glycosamino-
glycan (g) in a 14-week-old human
fetal elbow. The boxed areas labeled
skin, stroma, and perichondrium are
areas of the interest, which are pre-
sented at higher magnification in
later figures. Immunolocalization of
D-HS stub epitope generated by
predigestion of the section with he-
paritinase III and detected using
mAb 3G10 (h), native HS (mAb
10E4) (i), and 3B3[-] CS epitope (j)
are also depicted for the perichon-
drial area indicated in (f, g). CS,
chondroitin sulfate; HS, heparan
sulfate; mAb monoclonal antibody.
Color images available online at
www.liebertpub.com/scd
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collateral ligaments, strong fan-shaped ligaments, extend
from the medial epicondyle of the humerus to the proximal
ulna, and lateral epicondyle of the humerus to the head of
the radius to stabilize the elbow joint preventing excessive
abduction [21]. Morphological and histological studies have
described the development of the human fetal elbow [21–
24]; its vascular supply [25,26]; and the development of the
intra-and extra-capsular ligaments of the elbow [27].
Cellular events associated with fetal diarthroidal joint
formation and articular cartilage development have been
extensively studied [6,28–33]. An early event in fetal joint
development is the cellular condensation of mesenchyme
between cartilaginous limb elements to form a joint interzone
between the cartilage rudiments [23,24]. This interzone spe-
cifies the future joint line and serves as an important signaling
center, containing members of the TGF-b growth and differ-
entiation factors (GDFs) -5 & 6; BMP-2, 3 & 4 and fibroblast
growth factor (FGF) -2, 4 & 13 superfamilies; BMPs and
BMP-antagonists (Chordin & Noggin); and transcription fac-
tors that promote chondrogenesis [31,34].
The progenitor cells of the interzone give rise to the em-
bryonic joint connective tissue, the synovial cavity and the
joint articulating surfaces [6,8,9, 19,26,28]. The articular
chondrocytes derive from a distinct population of GDF-5-
positive interzone cells [30–33] while a Notch-1-positive
progenitor cell subpopulation has also been identified within
the articular cartilage surface zone [6,32,33]. Following joint
cavitation, the future articular cartilage expresses a number of
CS sulfationmotifs identified bymAbs 3B3[-], 7D4, and 4C3
[5,7,9,11,12] on a collection of matrix and cell membrane
PGs, but these appear absent from the interzone. The CS/
dermatan sulphate (DS) and heparan sulfate (HS) glycos-
aminoglycans (GAGs), play important roles in the binding/
sequestration and presentation of soluble signaling molecules
in biological systems via unique sulfation sequences
[5,7,9,34–38]; however, limited information is available on
their specific roles in joint morphogenesis and articular car-
tilage development [5,9,10].
In this study, we have examined the distribution of these
novel CS sulfation motifs within the fetal human elbow to
better define their potential roles in its development. Dis-
crete cell populations expressing the 7D4 and 4C3 CS
sulfation motifs were identified in the perichondrium and
the surface regions of the articular cartilages. The HS-
substituted PG perlecan was also strongly expressed in the
outermost regions of the perichondrium, hair bulbs, and
stromal progenitor cell niches in close association with, but
not colocalized, with the 4C3 and 7D4 CS sulfation motifs.
HS-PGs such as perlecan are important constituents of stem
cell niches and have roles in the establishment of growth
factor and morphogen gradients in developmental tissues,
which drives cellular migration and differentiation [39,40].
The role of the CS sulfation motifs in these processes,
however, remains to be fully elucidated.
The perichondrium has long been known as a source of
progenitor cells and a source of morphogens or signaling
molecules, which direct and regulate fetal cartilage and bone
formation [41–48]. With skeletal development the peri-
chondrium becomes vascularized and in adulthood is termed
the periosteum. All of the bone surfaces except those con-
taining articular cartilage are covered by the periosteum.
The periosteum/endostium are rich sources of progenitor
cells, which has led to their harvest to suture over cartilage
defects filled with autologous chondrocytes to promote
cartilage repair. Reconstructive surgery has also utilized the
periostium as a source of cells to drive cartilaginous re-
modeling and repair processes and support angiogenesis,
osteogenesis, and chondrogenesis [45–48]. This study has
further established that the CS sulfation motifs described are
markers of progenitor cell populations in the inner regions
of the perichondrium and in the hair bulb and rudiment-
associated stromal/perivascular niches in the developmental
human elbow joint.
Materials and Methods
Histochoice was an Amresco product. mAbs to perlecan
domain-I (mAb A76) and IV (mAb A7L6), were obtained from
abcam. Mouse monoclonals recognizing the distinct CS/DS
sulfation motifs (mAbs 3B3[-], 4C3, and 7D4) have been de-
scribed [11,12].MousemAbs toward nativeHS (mAb10E4) and
FIG. 2. Identification of D-HS stub epitope generated by
predigestion of the section with heparitinase III and native
HS immunolocalized using mAb 3G10 and 10E4 respec-
tively in a developing hair bulb and associated with skin in a
14-week-old human fetal elbow (a, b). The macroscopic
toluidine blue-stained sections (c) the general location of the
tissue area of interest. Immunolocalization of 3B3[-] CS
epitope (d); 7D4 CS sulfation motif (e) and 4C3 CS sulfa-
tion motif (f). Color images available online at www
.liebertpub.com/scd
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D-HS stubs generated by heparitinase digestion (mAb 3G10)
were purchased from AMS Biotechnology. Six elbow and eight
knee joints from 12 to 14-week-old human fetuses were obtained
with informed consent at termination of pregnancy with ethical
approval from the Human Care and Ethics Review Board of The
Royal North Shore Hospital, University of Sydney.
Isolation of perlecan from human fetal
knee joint rudiments
The femoral, tibial, and patellar cartilage rudiments from
eight 12–14 week gestational age human fetal knees were
trimmed of associated tissues, finely diced, and extracted in
FIG. 3. Immunolocalization of
native HS using mAb 10E4 (a–c)
in a stromal niche adjacent to the
ulna in a 14-week-old human fetal
elbow. This is the area labeled
stroma in Fig. 2a and b. The boxed
area in (a) is presented at higher
magnification in (b). Dotted lines
in (b) depict the demarcation of the
cartilage rudiment (cr) and stromal
tissue (s) and the edges of the loose
stromal connective tissue sur-
rounding the ulna rudiment. D-HS
stub epitope generated by predi-
gestion with heparitinase III is also
immunolocalized in the same stro-
mal area using mAb 3G10 (d) as
is CS epitope 3B3[-] (e) and
CS sulfation motif 7D4 (f). The
macroscopic toluidine blue-stained
photo segment in (g) depicts the
whole elbow joint with the boxed
stromal area of interest indicated.
Arrows depict small blood vessels
containing entrapped red blood
cells; arrowhead an arteriole; ar-
row labeled L denotes flattened
lymphatics. The asterisks in (c)
depict a 10E4 positive nerve plex-
us. Color images available online at
www.liebertpub.com/scd
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6M Urea 50mM Tris-HCl pH 7.2 containing protease in-
hibitors (Roche) (5mL) for 72 h at 4!C. The extract was
separated from tissue residue by filtration through a 45 mm
syringe filter and clarified by centrifugation (10,000 g ·
10min). The extract was applied to a 1mL Q-Sepharose
column and eluted with 6M urea 50mM Tris-HCl pH 7.2
0.3M NaCl (buffer A, 10mL) then with a linear gradient of
0.3–2.0M NaCl in buffer A (20mL). Fractions (0.25mL)
were collected into 96-well microtiter plates. Protein and
sulfated GAG were measured in each fraction using the
bicinchoninic acid protein assay and the metachromatic
dye 1,9-dimethylmethylene blue [49]. Perlecan eluted in
fractions 47–50 separated from aggrecan, which eluted
in fractions 55–70. Aliquots of individual fractions were
electrophoresed on 3%–8% polyacrylamide gradient (PAG)
Tis-acetate gradient gels and blotted to nitrocellulose50.
After blocking the blots were probed with antibodies to KS
(mAb 5D4) and perlecan domain-I (mAb A76). Blots were
also predigested with chondroitinase ABC (0.1 U/mL) in
50mMTris-acetate pH 6.8 containing 2%w/v bovine serum
albumin then blotted with mAb 2B6(+) to the chondroitin-4-
sulfate stub epitopes [50].
Some gels were also stained with toluidine blue. Samples
of the perlecan pool from anion exchange chromatography
were separated on 3%–8% PAG Tris-acetate gels and blot-
ted using mAbs A76 and 2B6(+). HiMark (InVitrogen)
prestained molecular weight standards were used for cali-
bration purposes for the blotting step. Purified endothelial
cell perlecan (Fig. 8A, lane 1) aggrecan from ovine articular
cartilage of 2, 3, and 4-year-old sheep (Fig. 8A, lanes 2–4),
CS (Fig. 8A, lane 5) and intervertebral disc (Fig. 8A, lane 6)
were also run as standards.
Preparation of human fetal elbow specimens
for histochemistry and immunohistochemistry
Human fetal elbows were fixed in Histochoice for 24 h.
The tissues were dehydrated in graded ethanol solutions
and embedded in paraplast wax. Four micrometers mid-
sagittal microtome sections were cut and attached to Su-
perFrost Plus glass microscope slides (Menzel-Glaser),
deparaffinized in xylene (two changes· 5min), and rehy-
drated through graded ethanol washes (100%–70% v/v) to
water. Sections destined for confocal immunolocalizations
were cut at 7 mM and treated identically.
Histochemistry
Sections were stained for 10min with 0.04% toluidine
blue in 0.1M sodium acetate buffer pH 4.0 to visualize
tissue PGs. This was followed by 2min counterstaining in
an aqueous 1% fast-green FCF stain to differentiate areas
stained for PG. Sections were also stained with hematoxylin
and eosin to examine cellular morphology.
Immunoperoxidase labeling
The CS sulfation motifs 4C3, 7D4, and 3B3[-], perle-
can (mAb A7L6), native HS (mAb 10E4), and D-HS stub
epitope (mAb 3G10) were immunolocalized in 4 mm
sections of human fetal elbow as specified previously [9].
The 3G10 HS stub epitope was generated by predigest-
ing the tissue sections with heparitinase III as indicated
earlier [9].
Brightfield photomicroscopy
Sections, processed as above, were digitally photo-
graphed under brightfield optics on a Leica DM6000 mi-
croscope (Leica).
Immunofluorescence and confocal laser
scanning microscopy
Sections were digested in proteinase K (500mg/mL) for
15min at room temperature. After washing for 5min in
FIG. 4. Immunolocalization of perlecan in the perichon-
drium of a 14-week-old human fetal elbow using laser-
assisted fluorescent confocal microscopy. Perlecan was
immunolocalized using mAb A7L6 to perlecan domain IV
and FITC-conjugated anti rat IgG, cell nuclei were stained
with DAPI. The toluidine blue-stained inset of the fetal el-
bow depicts the general area of the humerus perichondrium
(boxed area) from which the images were taken. The boxed
area in (a) is also provided at higher magnification in (b).
Putative stem cell niches bounded by perlecan are also
labeled in (b). Color images available online at www
.liebertpub.com/scd
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phosphate-buffered saline (pH 7.4) containing 0.001%
Tween-20 tissue sections were blocked with normal goat or
donkey serum (1:20 dilution) for 30min at room tempera-
ture, followed by overnight incubation at 4!C with 3B3[-],
4C3, and 7D4 hybridoma conditioned media (1:20 dilution),
or mAb A7L6 (2 mg/mL), respectively. The tissue sections
were then washed and a FITC-conjugated goat anti-mouse
or donkey anti-rat secondary antibody (1:200 dilution) ap-
plied for 1 h at room temperature to specifically target either
mouse or rat primary antibodies (ie, 3B3[-], 4C3, 7D4, and
A7L6 respectively). After a final wash, sections were
mounted under coverslips in Vectashield mountant (Vector
Laboratories) containing either DAPI or propidium iodide
for nuclear context. The fluorescently labeled tissue sections
were then scanned on a Leica TCS SP2 AOBS confocal
laser scanning microscope (Leica) using appropriate exci-
tation and emission settings for DAPI (Ex max: 359 nm; Em.
max: 461 nm), FITC (Ex max: 494 nm; Em max: 520 nm),
and propidium iodide (Ex max 536 nm; Em max: 617 nm).
Representative images were then imported into Microsoft
Powerpoint worksheets to assemble the composite histology
figures.
Results
Initial histological examination of two 12-week-old hu-
man fetal elbows using toluidine blue staining and im-
munolocalization of perlecan demonstrated the cartilaginous
nature of the elbow rudiment and widespread localization of
perlecan throughout the rudiments (Fig. 1a–e). Perlecan was
also immunolocalized to small vessel-like structures in the
perichondrial tissues (Fig. 1b, d, e). These structures did not
stain with antibodies to CD31, CD34, LYVE-1, and podo-
planin; thus, they did not represent vascular or lymphatic
structures (data not shown). Further analysis of perlecan
immunolocalization in a 14-week-old human fetal elbow
also showed a widespread distribution (Fig. 1f). The surface
regions of the perichondrial tissues also stained positively
for native HS and D-HS stub epitope and the 3B3[-] CS
motif (Fig. 1h–j).
FIG. 5. Immunolocalization us-
ing fluorescent confocal micros-
copy of 7D4 CS sulfation motif in
the humerus perichondrium of a
14-week-old human fetal elbow
(a). The boxed area in (a) is de-
picted at higher magnification in
(b) and the boxed area in (b) at
higher magnification in (c). The
7D4 epitope was visualized using
7D4 mAb and FITC-conjugated
anti mouse IgG, cell nuclei were
stained with propidium iodide. The
toluidine blue-stained macroscopic
inset view of the elbow depicts the
area of the humerus perichondrium
where the confocal images were
obtained. The putative perichon-
drial niche is labeled in (c) with
7D4 labeled progenitor cells, which
have been released from the niche
arrowed. Similar perlecan-rich ni-
ches are also evident in bright field
images in Fig. 1b, d, and e. Color
images available online at www
.liebertpub.com/scd
6 HAYES ET AL.
The heparitinase III-generated unsaturated HS stub epi-
tope and native HS were immunolocalized to hair bulbs and
epidermis of the skin overlying the elbow (Fig. 2b). The hair
had yet to erupt from the follicle but in some cases the
location of the hair stem was visible in cross section within
the bulb structure (Fig. 2a, b). The D-HS stub epitope had a
more widespread distribution than native HS in the hair bulb
and epidermis. Occasional small blood vessels were dis-
cernable in the dermis containing entrapped red blood cells,
the endothelial cells surrounding these also expressed D-HS
stub epitope and native HS (Fig. 2a) while native HS was
localized in the basement membrane underlying the dermis
(Fig. 2b). The CS sulfation motifs 3B3[-], 7D4, and 4C3
were also strongly expressed around and within the hair bulb
structures (Fig. 2d–f) with the 3B3[-] CS motif associated
with the hair bulb while the 7D4 and 4C3 CS sulfation
motifs were associated with discrete cell populations sur-
rounding the bulb. The 3B3[-], 7D4, and 4C3 motifs were
also immunolocalized to occasional small blood vessels in
the dermis and to a variable extent in the epidermis (Fig. 2d–
f). The 3B3[-] motif was expressed within the hair follicle
and in the epidermis, whereas the distribution of the 7D4
and 4C3 CS motifs were more extensive on the outer mar-
gins and surrounding the follicle and in the epidermis
(Fig. 2d–f).
The CS sulfation motifs 3B3[-], 7D4, 4C3, D-HS stub
epitope, and native HS were also immunolocalized to a
collection of small blood vessels and arterioles in the stro-
mal tissues adjacent to the elbow cartilage rudiments
(Fig. 3a–f). D-HS stub epitope and native HS were both
strongly immunolocalized to stromal blood vessels (Fig. 3a–d).
Native HS was also immunolocalized to a nerve plexus in
the stromal tissue (Fig. 3c). The 3B3[-] CS motif also had a
widespread distribution in the rudiment-associated stromal
tissues (Fig. 3e), whereas the 7D4 epitope was more
strongly associated with the cartilage rudiment than this
surrounding stromal tissue (Fig. 3f).
Confocal microscopy identified perlecan prominently in
the surface regions of the perichondrium (Fig. 4a) associated
with tube-like structures (Fig. 4b), these localizations were
distinguishable from perlecan immunolocalized pericellu-
larly around small blood vessels in the stromal connective
tissues surrounding the elbow rudiments (Fig. 3c–f). The
perichondrium contained two populations of cells of dif-
fering morphology, a more flattened surface zone population
that expressed perlecan and a more rounded cell population
in the inner perichondrial regions, which expressed the 7D4
and 4C3 CS epitopes. The inner perichondrial cells stained
positively for the 7D4 CS sulfation motif, which appeared
associated with a cell surface PG (Fig. 5a–c).
FIG. 6. Composite figure depict-
ing the immunolocalization of 4C3
CS sulfation motif labeling activated
chondroprogenitor cells in regions of
the presumptive articular cartilage of
the humerus and the perichondrium
of a 14-week-old human fetal elbow
using fluorescent confocal micros-
copy. The boxed areas (a–d) in
photosegment (e) are also depicted at
higher magnifications elsewhere in
the figure. The 4C3 epitope was vi-
sualized using 4C3 mAb and FITC-
conjugated anti mouse IgG, cell nu-
clei were stained with propidium
iodide. The toluidine blue-stained
macroscopic inset image depicts the
area of the humerus where the con-
focal images were obtained. These
arrows also depict blood vessels as
indicated earlier in the legend. Color
images available online at www
.liebertpub.com/scd
CS SULFATION MOTIFS AND FETAL ELBOW DEVELOPMENT 7
The 4C3 CS sulfation motif was also immunolocalized to
discrete cell populations in the inner perichondrial layer
(Fig. 6a) and to surface zone cells in the presumptive articular
cartilage (Fig. 6b–d). The 4C3 CS sulfation motif was im-
munolocalized around individual cells but was not expressed
by the flattened cells in the outer perichondrial layers (Fig. 6a–
d). The distribution of 4C3, 7D4, and perlecan in fetal knee
rudiment cartilage was similar to that found in the fetal elbow
(Fig. 7a–d). Immunoblotting (Fig. 8A–D) of individual frac-
tions from anion exchange separation of a knee rudiment ex-
tract (Fig. 8E) demonstrated successful separation of aggrecan
and versican from perlecan with perlecan eluting early in the
separation at*0.4M NaCl in the elution gradient in fractions
47–50 while aggrecan and versican eluted later in the gradient
in fractions 55–70 (Fig. 8E). Further examination of the per-
lecan pool by immunoblotting using mAb 2B6(+) to the
chondroitin-4 sulfate stubs andmAbA76 to perlecan domain-1
demonstrated a large molecular weight band of*460 kDa in
size, consistent with full-length perlecan (Fig. 8F).
Discussion
A number of publications have shown that fetal articular
cartilage has a stem/progenitor cell population located
within its surface regions [6,26,31,41,51] and that many of
these cells express the CS sulfation motifs 4C3, 7D4, 3B3[-],
and 6C3 [6,7,9]. The presence of cells expressing the 4C3
and 7D4 CS sulfation motifs within the presumptive articular
cartilage and perichondrial tissue of the fetal elbow observed
in this study provides further evidence of these as develop-
mental markers. Perlecan also has a widespread distribution
in articular cartilage and promotes chondrogenesis [52–56].
Perlecan was found localized to the surface regions of the
perichondrium in this study where it may provide a unique
niche microenvironment conducive to the maintenance of
progenitor cell populations underlying the fibrous perichon-
drium [42,43].
The perichondrium is a layer of dense irregular connec-
tive tissue that surrounds the cartilage of developing bone. It
consists of two separate layers: an outer fibrous layer and
inner chondrogenic layer. The fibrous, perlecan-rich layer
contains cells of a fibroblastic morphology while the chon-
drogenic layer contains chondroblasts or committed chon-
drocytes [53]. In this study these cells expressed the 4C3
and 7D4 CS epitopes, which was consistent with them as
differentiation markers [5,6,11,12,57]. Our study also con-
firmed the findings of Malgouries et al. [58] that hair bulb
cells expressed the CS sulfation motifs 4C3 and 7D4 [58],
the hair bulb is a well-known stem cell niche [59,60].
We also observed CS sulfation motif expression by dis-
crete cell populations in perivascular stromal niches adjacent
to the elbow cartilage rudiments; blood vessels were also
present in these stromal niches and have been suggested as a
source of perivascular MSCs [61,62]. The 4C3 and 7D4 CS
motifs thus had a widespread distribution in perichondrial,
hair bulb, stromal/perivascular, and skin stem cell niches.
The term stem cell niche was first introduced in 1978 by
Schofield [63]. The stem cell niche contains all the cellu-
lar and molecular factors in the stem cell microenvironment
that interact and regulate the stem cell. The niche provi-
des support and maintenance of the stem cell and regula-
tion of its proliferation and may also direct downstream
FIG. 7. Confocal immunolocalization of the 4C3 (a), 7D4
(b), and CS sulfation motifs in knee tibial cartilage. Perlecan
displayed a similar immunolocalization of perlecan in the
surface cartilage regions as in the fetal elbow (c). Perlecanwas
also immunolocalized surrounding endothelial cells in a stro-
mal rudiment-associated blood vessel and served as a perlecan
internal positive control (d). Cell nuclei are stained red with
propidium iodide, antibody localization in green (FITC).
Color images available online at www.liebertpub.com/scd
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differentiation and cell lineage development. Anchorage of
the stem cell to ECM components or brother stem cells in the
niche microenvironment is considered an important require-
ment for the retention of the stem cell in the niche and for its
slow turnover and self-renewal in the niche. A number of
interactions are important in the adhesion and retention of the
stem cell in the niche [64–67]. These include interactions with
the cadherin family [64], integrins, and cellular receptor-ECM
(CD-44: HA) [66], gap junction formations involving the
Connexin family, or niche cell-cell-stem interactions involv-
ing; Delta-1/Notch; stem cell factor-c-kit interactions. Perle-
can was also an ECM component of the hair bulb, stromal/
perivascular and perichondrial niches in this study. Perlecan is
a component of neural and epithelial limbal stem cell niches
[68,69] where the subtle variations in its HS side chain sub-
structure and diverse repertoire of interactive ligands [70]
provide a specific niche environment conducive to the regu-
latory conditions required for stem cell maintenance and under
appropriate stimulatory conditions the activation and release
of migratory progenitor cells from the niche. Stem cells and
their associated niche ECMs provide specialized local mi-
croenvironments important for the retention and self-renewal
of stem cells and their differentiation into multipotent cell
lineages.
Perlecan is also a key component of neural [68,69], al-
lantois [71], lymphatic [72], limbal [73], and bone marrow
[74,75] stem cell niches. Perlecan modulates stem cell-ECM
attachment and may modulate stem cell-integrin and stem
cell-cadherin family or other cell receptor interactions such
as VEGF2 [76] to influence stem cell survival, differentia-
tion, and proliferation [70,76,77]. Extrinsic interactions with
soluble growth factors such as FGF2 may also promote stem
cell survival [68,69] through the Wnt signaling pathways
[77]. By modulating such stem cell-matrix interactions
perlecan can help retain the stem cells within the niche to
undergo slow recycling and self renewal but can also in-
fluence the MSC daughter cells on the edge of the niche,
which can undergo further differentiation into specific cell
lineages and once freed of the adhesive constraints of the
niche can migrate to distant sites driven by morphogen
gradients also established by perlecan and its associated
ligands.
In this study the perichondrium was a niche for progenitor
cells, which subsequently migrated to populate the surface
zone cartilages and participated in proliferation, differentia-
tion, and matrix production to establish the articulating sur-
faces of the elbow joint. Cells of an osteoblastic lineage also
reside in the perichondrium and have roles in the transfor-
mation of the femoral and tibial rudiment cartilages into bone
as part of the endochondral ossification process, however,
they can also participate in intramembranous bone formation.
The GAG chains of PGs are versatile tools for both storing
and transferring information and much progress has been
made in understanding how this contributes to cellular reg-
ulatory processes and developmental and disease processes.
Until relatively recently heparin/HS and the heparanome had
been the major focus in this area of developmental biology
[78,79], however, a number of publications have now ap-
peared elucidating roles for CS in tissue development [35–
38,80].
Ongoing studies will undoubtedly identify specific CS
sequences and charge localizations and their interactive li-
gands and how they participate in the biological processes
that shape tissue development and repair. The CS sulfation
motifs 7D4 and 4C3 on cell-associated PGs serve to im-
mobilize growth factors/morphogens actively involved in
tissue development [5,11,12,57]. The unique distributions of
these CS sulfation motifs with surface zone progenitor cells
in articular cartilage [6–9] and in tissue niches associated
with histogenesis and tissue differentiation [10–12] suggests
that they may identify an early stage of stem/progenitor cell
differentiation. Previous studies indicate that these progen-
itor cell populations play roles in hematopoiesis, skin mor-
phogenesis, chondrogenesis, and IVD development [6–
9,11,12].
The findings of this study indicate they also have im-
portant roles to play in the development of the human fetal
elbow joint and associated connective tissues. Moreover,
detection of the 4C3 and 7D4 positive progenitor cells may
provide a means of monitoring their roles in joint devel-
opment. The precise mode of action of MSCs/progenitor
cells in tissue repair and development has been hampered by
the lack of definitive markers to identify these cells, the 4C3
and 7D4 CS sulfation motifs are expressed by activated
migratory stem cell populations in developing/remodeling
tissues and thus may represent a useful means of monitoring
FIG. 8. Toluidine blue staining (A) and immunoblotting
(B–D) of individual fractions from an anion exchange sep-
aration (E) demonstrating the separation of human knee
rudiment perlecan from aggrecan and versican. Perlecan in
fractions 47–50 was pooled and immunoblotted (F). mAb
2B6(+) to the core protein chondroitin-4-sulfate stubs and
mAb A76 to perlecan domain-1 identified a large molecular
weight form of perlecan of *460 kDa. This was a CS-HS
hybrid proteoglycan. The lane numbers in A delineate
fraction numbers from the anion exchange chromatography.
The dotted circles depict the 2B6(+) and A76 positive
perlecan bands on the blots well separated from 2B6(+)
versican/aggrecan. The dotted line in E depicts the progress
of the NaCL gradient elution.
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such cells. Perlecan was subsequently isolated in this study
from human fetal knee joint rudiments using anion exchange
chromatography. Immunoblotting demonstrated that perle-
can in fetal rudiment cartilage was a hybrid CS-HS PG.
Conclusions
The application of mAbs to the CS sulfation motifs 4C3,
7D4, and 3B3[-] to localize and differentiate the activated
progenitor cell populations from the resident connective
tissue cell populations may be useful in their identification
and elucidation of their prospective roles in tissue devel-
opment and ECM remodeling.
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